ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,133,755 | -37.6% | 13,625,022 | -3.8% | 0.42% | -18.3% |
Q1 2023 | $5,020,488 | -13.4% | 14,166,163 | -21.5% | 0.51% | +69.9% |
Q4 2022 | $5,794,258 | -56.0% | 18,056,274 | 0.0% | 0.30% | -60.8% |
Q3 2022 | $13,181,000 | -18.9% | 18,056,274 | 0.0% | 0.76% | -19.1% |
Q2 2022 | $16,245,000 | -10.8% | 18,056,274 | +47.7% | 0.94% | +59.6% |
Q1 2022 | $18,214,000 | -31.3% | 12,223,953 | 0.0% | 0.59% | -38.5% |
Q4 2021 | $26,526,000 | -39.0% | 12,223,953 | 0.0% | 0.96% | -27.4% |
Q3 2021 | $43,517,000 | -38.0% | 12,223,953 | 0.0% | 1.32% | -39.4% |
Q2 2021 | $70,165,000 | +10.6% | 12,223,953 | 0.0% | 2.18% | +20.8% |
Q1 2021 | $63,442,000 | +322.5% | 12,223,953 | +94.6% | 1.81% | +231.1% |
Q4 2020 | $15,016,000 | +79.4% | 6,282,823 | +4.3% | 0.55% | +26.7% |
Q3 2020 | $8,371,000 | -26.8% | 6,022,534 | +0.6% | 0.43% | -60.8% |
Q2 2020 | $11,429,000 | -16.4% | 5,983,724 | +7.3% | 1.10% | -32.3% |
Q1 2020 | $13,667,000 | +6.6% | 5,578,283 | -2.1% | 1.62% | +43.9% |
Q4 2019 | $12,817,000 | – | 5,696,576 | – | 1.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 2,982,557 | $5,697,000 | 6.44% |
BROADWOOD CAPITAL INC | 14,716,204 | $28,108,000 | 2.20% |
PURA VIDA INVESTMENTS, LLC | 5,983,724 | $11,429,000 | 1.10% |
Mesirow Financial Investment Management, Inc. | 99,282 | $190,000 | 0.90% |
P.A.W. CAPITAL CORP | 200,000 | $382,000 | 0.43% |
Penbrook Management LLC | 215,625 | $412,000 | 0.40% |
EAM Investors, LLC | 241,769 | $462,000 | 0.10% |
Private Wealth Partners, LLC | 150,000 | $287,000 | 0.04% |
Phoenix Holdings Ltd. | 292,275 | $597,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 145,650 | $470,000 | 0.02% |